Bookmark and Share

Christopher  Welsh

Christopher Welsh M.D.

Academic Title: Associate Professor
Primary Appointment: Psychiatry
Additional Title(s): Medical Director-UMMC Substance Abuse Consultation Service; Medical Director-UMMC Comprehensive Recovery Program;
Location: UMMC, P1H10
Phone: (410) 328-3716
Fax: (410) 328-7919

Clinical Speciality:

Dr. Welsh’s main area of clinical work is in the areas of addiction and dual diagnosis. He works in various in- and out-patient settings, including methadone and buprenorphine maintenance. He also has an interest in the medical complications of addiction and is the medical director of the UMMC Substance Abuse Consultation Service, which is responsible for substance abuse assessment and intervention with patients throughout the University of Maryland Medical Center. He has also worked with the Baltimore City Department of Health on the needle-exchange and opioid overdose prevention projects.

Dr. Welsh also has an interest in impairment in health-care professionals and is the chairman of the UMMC Professional Assistance Committee, which provides assistance to the medical staff for a wide range of impairments.  He works on local and national committees to help address issues around physician impairment.

Dr. Welsh also has an interest in medical education, with a focus on the education of students, residents and practicing physicians about addiction. He is also interested in the effect of television and film on the perception of addiction and the use of media in medical education. He is involved with several local and national committees and initiatives focusing on medical education about addiction.


Welsh, C. & Liberto, J. “Medication For Relapse Prevention In Substance Dependence Disorders”; Journal  Of Psychiatric Practice; 7(1); 2001.

Welsh, C., Cohen, A., Weintraub, E. et al; “The Use of Intravenous Buprenorphine in the Treatment of Opioid Withdrawal in Medically Ill Patients”; American Journal of Addictions; 11; 2002.

Welsh, C. & Doyon, S. Seizure Induced by Insufflation of Bupropion. The New England Journal of Medicine, 347(12), 2002.

Welsh, C. & Cargiulo, T. “Nevirapine Induced Opioid Withdrawal in a Patient Previously Stable on Levo-Alpha-Acetyl-Methadol (LAAM).”  Journal of Maintenance In the Addictions; 2(3), 2003.

Welsh, C. “OD’s and DT’s: Using Movies to Teach Intoxication and Withdrawal Syndromes to Medical Students.” Academic Psychiatry; 27(3), 2003.

Welsh, C., “TRAPPED: A Mnemonic for Taking A Substance Use History.” Academic Psychiatry; 27(4), 2003.

Welsh, C., et al; “The role of Diagnostic Systems in the Continued Stigmatization of Patients With Opioid Dependence”; Psychiatric Services; 55(1), 2004.

Welsh, C.  “Harry Potter and the Butterbeer: Can We Use This To Talk to Kids About Alcohol?” Journal of the American Academy of Child and Adolescent Psychiatry; 43(1), 2004

Welsh, C. & Doniger, J. “Commentary on The Corner” Academic Medicine; 79(12), 2004.

Welsh, C. “Check Out My Bottle Collection.” Substance Abuse; 25(3), 2005.

Walsh, J. Flegl, R., Atkins, R., Cangianelli, L., Cooper, C., Welsh, C., Kerns, T. “Drug and Alcohol Use Among Drivers Admitted to a Level -1 Trauma Center”.” Accident Analysis & Prevention; 37, 2005.

Welsh, C. & Valadez-Meltzer, A. “Buprenorphine: A (Relatively) New Treatment for Opioid Dependence.” Psychiatry 2005; 2(12), 2005.

Doyon, S., Klein-Schwartz, W., Welsh, C. “Toxicity Following Buprenorphine Ingestions.” Clinical Toxicology; 43(6), 2005

Doyon, S. & Welsh, C. “Life-threatening Toxicity From Intravenous Injection of Benzonatate.” Clinical Toxicology; 43(6), 2005.

Donaher, P and Welsh, C., “Managing Opioid Addiction with Buprenorphine.” American Family Physician. 73(9), 2006.